Zhong Xiaojie

Chief Physician

Specialized in treating benign diseases such as breast hyperplasia, nipple discharge, breast fibroadenoma, and intraductal papillomatosis, with extensive experience in the early detection and diagnosis of breast cancer. In the treatment of breast cancer, we closely follow international trends and adopt different treatment methods based on the actual situation of patients, such as modified mastectomy, breast conserving surgery, one-stage and two-stage reconstruction after breast cancer surgery. We are skilled in the comprehensive treatment of breast cancer, chemotherapy for advanced breast cancer, molecular targeted therapy, and endocrine therapy. In clinical work, we are adept at scientifically exploring clinical difficult problems, using the latest research results to guide clinical work, and implementing the best individualized treatment plan.

Introduction of the expert

Chief Physician, graduated from Sun Yat-sen Medical University. He/She is the first to promote sentinel lymph node biopsy technology, breast minimally invasive surgery technology, and breast reconstruction surgery for breast cancer in Hainan Province.

Medical specialty

I. Treat benign diseases such as breast hyperplasia, nipple discharge, breast fibroadenoma, and intraductal papillomatosis. We have rich experience in early detection and diagnosis of breast cancer. In the treatment of breast cancer, we closely follow international trends and adopt different treatment methods based on the actual situation of patients, such as modified mastectomy, breast conserving surgery, and one-stage and two-stage reconstruction after breast cancer surgery.

II. Comprehensive treatment of breast cancer, chemotherapy for advanced breast cancer, molecular targeted therapy, and endocrine therapy. In clinical practice, I am adept at conducting scientific exploration on clinical difficult problems, applying the latest research findings to guide clinical work, and implementing optimal individualized treatment plans.

Academic association appointment

I. Director of the Breast Cancer Professional Committee of the Hainan Provincial Anti-Cancer Association

II. Vice Chairman of the Breast Tumor Professional Committee of the Hainan Provincial Cancer Prevention and Treatment Association

III. Vice Chairman of the MDT Professional Committee of the Hainan Provincial Cancer Prevention and Control Association

IV. Standing Committee Member of the Oncology Branch of the Hainan Provincial Medical Association

V. Member of the Breast Disease Professional Committee of the China Medical Education Association

VI. Member of the 7th, 8th, and 9th Committees of the Breast Cancer Specialty Committee of the Chinese Anti-Cancer Association

VII. Chairman of the First Hainan Provincial Medical Doctor Association Breast Surgery Branch

VIII. Honorary Chairman of the Breast Surgery Branch of the Hainan Provincial Medical Doctor Association

Papers and works

I. Clinical experience of valve replacement with left heart drainage-myocardial protection in 120 cases, Journal of Hainan Medical University. 2000, (01), second author, 2000.

II. Thoracoscopic lobectomy, Chinese Journal of Endoscopy. 2001, (02), second author, 2001.

III. Video-assisted thoracoscopic mini-incision for resection of mediastinal tumors and cysts, Chinese Journal of Endoscopy. 2002, (02), first author, 2002.

IV. Clinical efficacy of neoadjuvant chemotherapy in stage III operable breast cancer, Chinese Journal of Tropical Medicine. 2005, (08), first author, 2005.

V. A case of Pagets disease of the breast, Hainan Medical Journal. 2011, 22(24), second author, 2011.

VI. Diagnosis and Treatment of Occult Breast Cancer, Evidence-Based Medicine. 2012, 12(01), Second Author, 2012.

VII. A Brief Analysis of Medical Ethics and Teacher Ethics for Clinical Teachers in Medical Colleges and Universities, Modern Distance Education of Chinese Medicine, 2019, 17(07), Second Author, 2019.

VIII. Quantitative Analysis of Anastomotic Stoma Patency: Application in One Case of Preventive Lymphatic-Venous Anastomosis During Axillary Lymph Node Dissection for Breast Cancer, Tissue Engineering and Reconstructive Surgery. 2022, 18(01), Co-authored, 2022.